Yosuke Maeda

1.6k total citations
68 papers, 1.3k citations indexed

About

Yosuke Maeda is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Yosuke Maeda has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Virology, 35 papers in Immunology and 30 papers in Infectious Diseases. Recurrent topics in Yosuke Maeda's work include HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (24 papers) and Immune Cell Function and Interaction (18 papers). Yosuke Maeda is often cited by papers focused on HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (24 papers) and Immune Cell Function and Interaction (18 papers). Yosuke Maeda collaborates with scholars based in Japan, United States and China. Yosuke Maeda's co-authors include Shinji Harada, Shuzo Matsushita, Keisuke Yusa, David Venzon, Atsushi Koito, Kazuaki Monde, Kiyoshi Takatsuki, Toshio Hattori, Hiroaki Mitsuya and Mari Kannagi and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Yosuke Maeda

68 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yosuke Maeda 645 582 409 396 205 68 1.3k
Atsushi Koito 1.1k 1.7× 574 1.0× 556 1.4× 775 2.0× 294 1.4× 43 1.8k
Sonsoles Sánchez‐Palomino 511 0.8× 374 0.6× 419 1.0× 233 0.6× 136 0.7× 45 1.1k
Thierry Huet 713 1.1× 482 0.8× 423 1.0× 203 0.5× 296 1.4× 18 1.2k
B. Öberg 488 0.8× 624 1.1× 495 1.2× 175 0.4× 644 3.1× 67 1.6k
Zhujun Ao 552 0.9× 538 0.9× 460 1.1× 192 0.5× 280 1.4× 45 1.0k
Sebla B. Kutluay 899 1.4× 504 0.9× 860 2.1× 522 1.3× 394 1.9× 31 1.7k
Yossef Raviv 391 0.6× 335 0.6× 501 1.2× 173 0.4× 163 0.8× 27 1.2k
Małgorzata Kęsik-Brodacka 685 1.1× 305 0.5× 483 1.2× 578 1.5× 312 1.5× 20 1.4k
Christine Goffinet 563 0.9× 395 0.7× 330 0.8× 580 1.5× 325 1.6× 41 1.3k
Masashi Tatsumi 544 0.8× 474 0.8× 335 0.8× 258 0.7× 148 0.7× 63 1.1k

Countries citing papers authored by Yosuke Maeda

Since Specialization
Citations

This map shows the geographic impact of Yosuke Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Maeda more than expected).

Fields of papers citing papers by Yosuke Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosuke Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Maeda. The network helps show where Yosuke Maeda may publish in the future.

Co-authorship network of co-authors of Yosuke Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Maeda. A scholar is included among the top collaborators of Yosuke Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Maeda. Yosuke Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiyoshi, Masateru, Akira Ono, Yosuke Maeda, et al.. (2025). M-Sec promotes the accumulation of intracellular HTLV-1 Gag puncta and the incorporation of Env into viral particles. PLoS Pathogens. 21(1). e1012919–e1012919. 1 indexed citations
2.
Maeda, Yosuke, Mako Toyoda, Takeo Kuwata, et al.. (2024). Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2. International Journal of Molecular Sciences. 25(2). 1353–1353. 1 indexed citations
3.
Iwasaki, Hiroko, Yosuke Maeda, Toshiro Niki, et al.. (2023). Plasma N-Cleaved Galectin-9 Is a Surrogate Marker for Determining the Severity of COVID-19 and Monitoring the Therapeutic Effects of Tocilizumab. International Journal of Molecular Sciences. 24(4). 3591–3591. 6 indexed citations
4.
Ono, Katsuhiko, T. Shiba, Tianli Zhang, et al.. (2023). Alkyl gallates inhibit serine O-acetyltransferase in bacteria and enhance susceptibility of drug-resistant Gram-negative bacteria to antibiotics. Frontiers in Microbiology. 14. 1276447–1276447. 4 indexed citations
5.
Monde, Kazuaki, Yorifumi Satou, Mizuki Goto, et al.. (2022). Movements of Ancient Human Endogenous Retroviruses Detected in SOX2-Expressing Cells. Journal of Virology. 96(9). e0035622–e0035622. 9 indexed citations
6.
OHTSUKA, Hiromichi, Maki N. Inoue, Yosuke Maeda, Taishi Tanabe, & Motoshi Tajima. (2018). Effect of Pasteurella multocida Soluble Antigen Stimulation on the In Vitro Response of Peripheral Blood Mononuclear Cells of Holstein Calves. Acta veterinaria. 68(2). 201–210. 2 indexed citations
7.
Monde, Kazuaki, Yusuke Nakano, Ferri Soheilian, et al.. (2017). Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity. Retrovirology. 14(1). 27–27. 37 indexed citations
8.
Toyoda, Mako, Yoko Ogata, Yosuke Maeda, et al.. (2015). Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors. Journal of Virology. 89(18). 9639–9652. 21 indexed citations
10.
Maeda, Yosuke, Yusuke Nakano, Kazuaki Monde, et al.. (2014). V3-Independent Competitive Resistance of a Dual-X4 HIV-1 to the CXCR4 Inhibitor AMD3100. PLoS ONE. 9(2). e89515–e89515. 1 indexed citations
11.
Yokoyama, Masaru, et al.. (2013). Structure and Dynamics of the gp120 V3 Loop That Confers Noncompetitive Resistance in R5 HIV-1JR-FL to Maraviroc. PLoS ONE. 8(6). e65115–e65115. 16 indexed citations
12.
Monde, Kazuaki, Yosuke Maeda, Yuetsu Tanaka, Shinji Harada, & Keisuke Yusa. (2007). Gp120 V3-dependent Impairment of R5 HIV-1 Infectivity Due to Virion-incorporated CCR5. Journal of Biological Chemistry. 282(51). 36923–36932. 7 indexed citations
13.
Yoshimura, Kazuhisa, Junji Shibata, Tetsuya Kimura, et al.. (2006). Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS. 20(16). 2065–2073. 23 indexed citations
14.
Harada, Shinji, Keisuke Yusa, Kazuaki Monde, Takaaki Akaike, & Yosuke Maeda. (2005). Influence of membrane fluidity on human immunodeficiency virus type 1 entry. Biochemical and Biophysical Research Communications. 329(2). 480–486. 22 indexed citations
15.
Makino, Masahiko, et al.. (2001). Association of CD40 Ligand Expression on HTLV‐I‐Infected T Cells and Maturation of Dendritic Cells. Scandinavian Journal of Immunology. 54(6). 574–581. 22 indexed citations
16.
Tsuda, Hiroyuki, et al.. (1994). Parvovirus B19‐associated haemophagocytic syndrome with prominent neutrophilia. British Journal of Haematology. 86(2). 413–414. 20 indexed citations
17.
Maeda, Hiroaki, Kazuhiko Kimachi, Yasuyuki Eda, et al.. (1992). Characterization of a Mouse/Human Chimeric Monoclonal Antibody (Cβ1) to a Principal Neutralizing Domain of the Human Immunodeficiency Virus Type 1 Envelope Protein. AIDS Research and Human Retroviruses. 8(6). 1107–1115. 11 indexed citations
18.
Maeda, Yosuke, et al.. (1992). Changes in the Reactivity and Neutralizing Activity of a Type-Specific Neutralizing Monoclonal Antibody Induced by Interaction of Soluble CD4 with gp120. AIDS Research and Human Retroviruses. 8(12). 2049–2054. 6 indexed citations
19.
Koito, Atsushi, et al.. (1990). Selective Killing of HIV-Infected Cells by Anti-gp120 Immunotoxins. AIDS Research and Human Retroviruses. 6(2). 193–203. 24 indexed citations
20.
Hattori, Toshio, Atsushi Koito, Shuzo Matsushita, et al.. (1989). Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Research. 11(5-6). 255–261. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026